News & Articles

Affimer technology will potentially provide significant advantages over antibody fragment technology currently used in CAR-T cell modification

Learn how multi-channel flow cytometry is facilitating lung fibrosis research at the Medical University of South Carolina

New registration company offers advanced features

Using circulating cell-free DNA to analyze pancreatic cancer

Guest Editor, Randall Evans, Ph.D of Biodesix, discusses the recent success of a clinical trial of a diagnostic blood test

Interview with: Gary Romano, Head of Development, Alzheimer’s Disease & Neurology, Johnson and Johnson

Avacta collaborates to develop rapid tests to differentiate between viral and bacterial infections and to differentiate bacterial strains

The research will be carried out at Plasticell and in the laboratory of Dr. Eva Szegezdi at the Apoptosis Research Centre, NUI Galway

SelectScience Introduces New On-Line Directory

The ELRIG annual conference celebrates its 10 year anniversary

Highly specific assays allow for detection of minor allele frequencies down to 0.1%

Dr Ben Prosser discusses his mechanobiology research, recently published in Science

Oncomine Cell-Free DNA Assay is designed to target and detect mutations down to 0.1 percent allele frequencies from whole blood derived from lung cancer tumors

Find out how new immunoassay techniques are being used to analyze samples from preclinical and clinical trials

Studies show droplet volume liquid biopsy detects new tumor mass earlier than current imaging methods and detects more mutations than tissue biopsy

SelectScience® spoke to Rebecca Gentile, Senior Specialist in Quality, Vaccine and Biological Stability at Merck, about the future and current challenges of her work

Thermo Scientific Orbitrap Tribrid mass spectrometers employing the Tandem Mass Tags (TMT) enables researchers to better understand the proteome

Professor Joon Won Park is head of the lab at POSTECH aims to utilize the high sensitivity of AFM for applications in medical diagnostics

Dr Kirk McManus describes how 3D cell culture is advancing his cancer research